-
ECONOMIC IMPACT OF DIGITAL HEALTH SOLUTIONS: INSIGHTS FROM PETERSON HEALTH TECHNOLOGY INSTITUTE ASSESSMENTS
Mar 18, 2026, 21:38 PM -
ANALYSIS OF GENE THERAPIES AUTHORIZED BY HEALTH CANADA, AND COMPARISON WITH THE U.S. FOOD AND DRUG ADMINISTRATION, AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM -
QUALITY FIRST: MODERNIZING THE NURSING CURRICULUM FOR ACCREDITED HEALTHCARE
Mar 18, 2026, 21:38 PM -
STRENGTHENING MATERNAL CARE SYSTEMS IN LOW- AND MIDDLE-INCOME COUNTRIES: MODELING THE ACCESS, HEALTH, AND ECONOMIC IMPACT OF SFLT-1/PLGF TESTING FOR PREECLAMPSIA
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF RITLECTINIB FOR TREATMENT OF ALOPECIA AREATA IN A TERTIARY GOVERNMENT HOSPITAL IN RIYADH
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA IN DEMENTIA RESEARCH: IMPLICATIONS FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
SOCIAL AND STRUCTURAL DETERMINANTS OF BUPRENORPHINE ADHERENCE AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN JAPANESE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS INITIATING EFGARTIGIMOD: A REAL-WORLD RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
AI ADOPTION AND SENTIMENT AMONG CHINESE PHYSICIANS: BENCHMARKING THE “DIGITAL CONFIDENCE GAP” IN 2025
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF NATIONAL HTA DECISIONS IN ANTINEOPLASTIC, IMMUNOMODULATORY, AND NERVOUS SYSTEM THERAPIES ACROSS FOUR EUROPEAN COUNTRIES
Mar 18, 2026, 21:38 PM -
THE COST OF INEQUITY: ESTIMATING THE IMPACT OF DELAYED ACCESS TO NEOADJUVANT PERTUZUMAB IN CANADA
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
EFFICACY OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS IN REAL-WORLD SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
RISKY BUSINESS: HOW HEALTH PREFERENCE RESEARCH CAPTURES RISK TOLERANCE
Mar 18, 2026, 21:38 PM -
AVAILABILITY, PRICES, AND AFFORDABILITY OF ESSENTIAL MEDICINES FOR CARDIOVASCULAR DISEASES AND DIABETES: A MULTI-REGIONAL SURVEY ACROSS PAKISTAN
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS AND SAFETY OF GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH WEIGHT RECURRENCE AFTER BARIATRIC SURGERY: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
SYSTEMATIC SYNTHESIS OF DIRECT EBOLA OUTBREAK RESPONSE COSTS FOR COST-EFFECTIVENESS MODELLING
Mar 18, 2026, 21:38 PM -
OFF-LABEL USE AND ADHERENCE TO GLP-1S AS ADJUNCT THERAPY IN TYPE 1 DIABETES: A COMPARATIVE ANALYSIS VERSUS METFORMIN
Mar 18, 2026, 21:38 PM
